These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
762 related items for PubMed ID: 23076960
1. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Horsley A, Jones AM. Cochrane Database Syst Rev; 2012 Oct 17; 10():CD009529. PubMed ID: 23076960 [Abstract] [Full Text] [Related]
3. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Lord R, Jones AM, Horsley A. Cochrane Database Syst Rev; 2020 Apr 02; 4(4):CD009529. PubMed ID: 32239690 [Abstract] [Full Text] [Related]
4. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. Regan KH, Bhatt J. Cochrane Database Syst Rev; 2014 Oct 24; (10):CD009876. PubMed ID: 25342425 [Abstract] [Full Text] [Related]
5. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. Regan KH, Bhatt J. Cochrane Database Syst Rev; 2016 Nov 02; 11():CD009876. PubMed ID: 27804115 [Abstract] [Full Text] [Related]
10. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Amin R, Waters V. Cochrane Database Syst Rev; 2016 Jul 14; 7(7):CD009249. PubMed ID: 27415821 [Abstract] [Full Text] [Related]
11. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Waters V, Ratjen F. Cochrane Database Syst Rev; 2017 Jun 19; 6(6):CD006961. PubMed ID: 28628280 [Abstract] [Full Text] [Related]
12. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. St Denis M, Ramotar K, Vandemheen K, Tullis E, Ferris W, Chan F, Lee C, Slinger R, Aaron SD. Chest; 2007 Apr 19; 131(4):1188-96. PubMed ID: 17426227 [Abstract] [Full Text] [Related]
13. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Smith S, Waters V, Jahnke N, Ratjen F. Cochrane Database Syst Rev; 2020 Jun 10; 6(6):CD009528. PubMed ID: 32520436 [Abstract] [Full Text] [Related]
14. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Amin R, Waters V. Cochrane Database Syst Rev; 2012 May 16; (5):CD009249. PubMed ID: 22592739 [Abstract] [Full Text] [Related]
15. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Smith S, Ratjen F, Remmington T, Waters V. Cochrane Database Syst Rev; 2020 May 15; 5(5):CD006961. PubMed ID: 32412092 [Abstract] [Full Text] [Related]
16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V, Ratjen F. Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009528. PubMed ID: 23152277 [Abstract] [Full Text] [Related]
17. Antibiotic therapy for chronic infection with <I>Burkholderia cepacia</I> complex in people with cystic fibrosis. Frost F, Shaw M, Nazareth D. Cochrane Database Syst Rev; 2021 Dec 10; 12(12):CD013079. PubMed ID: 34889457 [Abstract] [Full Text] [Related]
18. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Amin R, Waters V. Cochrane Database Syst Rev; 2014 Apr 02; (4):CD009249. PubMed ID: 24696136 [Abstract] [Full Text] [Related]
19. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Amin R, Jahnke N, Waters V. Cochrane Database Syst Rev; 2020 Mar 18; 3(3):CD009249. PubMed ID: 32189337 [Abstract] [Full Text] [Related]